TY - JOUR
T1 - Calciphylaxis
T2 - Diagnostic and Treatment Advances for the Inpatient Dermatologist
AU - Kabbur, Gowri
AU - Miller, Daniel D.
N1 - Publisher Copyright:
© 2020, Springer Science+Business Media, LLC, part of Springer Nature.
Copyright:
Copyright 2020 Elsevier B.V., All rights reserved.
PY - 2020/12
Y1 - 2020/12
N2 - Purpose of Review: Calciphylaxis is a rare, life-threatening condition that frequently requires inpatient dermatology management. This article provides a comprehensive overview of the risk factors, classification, and pathogenesis of calciphylaxis, and summarizes current evidence for diagnostic testing and multi-disciplinary therapeutic management. Recent Findings: The two major subtypes of calciphylaxis tend to present in different anatomic locations, with non-uremic lesions favoring the distal extremities. Skin biopsies obtained on the distal extremities are more sensitive in detecting calciphylaxis-related vascular calcifications, compared to other sites. Underlying hypercoagulable disorders are common among calciphylaxis patients, implicating thrombosis as a major mediator of this disease and highlighting the potential therapeutic role of anticoagulants. Summary: Calciphylaxis is a challenging condition to treat, requiring multi-disciplinary care from dermatology, nephrology, pain medicine, plastic/general surgery, and palliative care. Inpatient dermatologists should be aware of the risk factors associated with calciphylaxis and focus therapy with pharmacologic agents and local wound care.
AB - Purpose of Review: Calciphylaxis is a rare, life-threatening condition that frequently requires inpatient dermatology management. This article provides a comprehensive overview of the risk factors, classification, and pathogenesis of calciphylaxis, and summarizes current evidence for diagnostic testing and multi-disciplinary therapeutic management. Recent Findings: The two major subtypes of calciphylaxis tend to present in different anatomic locations, with non-uremic lesions favoring the distal extremities. Skin biopsies obtained on the distal extremities are more sensitive in detecting calciphylaxis-related vascular calcifications, compared to other sites. Underlying hypercoagulable disorders are common among calciphylaxis patients, implicating thrombosis as a major mediator of this disease and highlighting the potential therapeutic role of anticoagulants. Summary: Calciphylaxis is a challenging condition to treat, requiring multi-disciplinary care from dermatology, nephrology, pain medicine, plastic/general surgery, and palliative care. Inpatient dermatologists should be aware of the risk factors associated with calciphylaxis and focus therapy with pharmacologic agents and local wound care.
KW - Calcific uremic arteriolopathy
KW - Calciphylaxis
KW - Hypercoagulable disorders
KW - Retiform purpura
KW - Vascular calcifications
KW - Wound care
UR - http://www.scopus.com/inward/record.url?scp=85092735666&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85092735666&partnerID=8YFLogxK
U2 - 10.1007/s13671-020-00316-z
DO - 10.1007/s13671-020-00316-z
M3 - Review article
AN - SCOPUS:85092735666
SN - 2162-4933
VL - 9
SP - 244
EP - 255
JO - Current Dermatology Reports
JF - Current Dermatology Reports
IS - 4
ER -